Generali Asset Management SPA SGR Grows Stock Holdings in Semler Scientific Inc. $SMLR

Generali Asset Management SPA SGR lifted its position in Semler Scientific Inc. (NASDAQ:SMLR) by 42.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 100,000 shares of the company’s stock after buying an additional 30,000 shares during the quarter. Generali Asset Management SPA SGR owned approximately 0.66% of Semler Scientific worth $3,000,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Vontobel Holding Ltd. purchased a new stake in Semler Scientific during the third quarter worth about $426,000. Corient Private Wealth LLC purchased a new position in shares of Semler Scientific in the second quarter valued at approximately $387,000. Nomura Holdings Inc. grew its holdings in shares of Semler Scientific by 5.8% in the second quarter. Nomura Holdings Inc. now owns 37,824 shares of the company’s stock valued at $1,465,000 after purchasing an additional 2,062 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in Semler Scientific by 354.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,819 shares of the company’s stock worth $70,000 after buying an additional 1,419 shares during the period. Finally, BNP Paribas Financial Markets increased its stake in Semler Scientific by 2,390.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 9,340 shares of the company’s stock worth $362,000 after buying an additional 8,965 shares during the period. Institutional investors and hedge funds own 49.37% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on SMLR. Benchmark dropped their price target on shares of Semler Scientific from $101.00 to $86.00 and set a “buy” rating for the company in a research note on Tuesday, September 23rd. Maxim Group decreased their target price on Semler Scientific from $95.00 to $80.00 and set a “buy” rating for the company in a report on Friday, September 19th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Semler Scientific in a research note on Monday, December 29th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $74.25.

Semler Scientific Price Performance

Semler Scientific stock opened at $17.78 on Friday. The company has a current ratio of 1.97, a quick ratio of 1.95 and a debt-to-equity ratio of 0.21. The company has a fifty day simple moving average of $20.91 and a 200-day simple moving average of $28.91. The stock has a market cap of $271.68 million, a P/E ratio of 6.40 and a beta of 1.32. Semler Scientific Inc. has a 12-month low of $14.89 and a 12-month high of $66.50.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Wednesday, November 12th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $1.21. The company had revenue of $7.49 million for the quarter, compared to analysts’ expectations of $7.87 million. Semler Scientific had a return on equity of 34.21% and a net margin of 130.80%.

Semler Scientific Company Profile

Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.

The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.